APP
OM icon

Alpha Paradigm Partners’s Outset Medical OM Stock Holding History

Alpha Paradigm Partners’s Portfolio OM Stock Details OM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$374K Buy
+966
New +$272K 0.15% 209

Other funds holding OM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
EHI
Eagle Health Investments Greenwich, Connecticut $572M AUM 67.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Alpha Paradigm Partners's OM Position: Q4 2022 in Review

Alpha Paradigm Partners opened a new position in Outset Medical (OM) in Q4 2022: 966 shares worth $374K. The stake represents 0.15% of the portfolio and ranks #209 among its holdings.

152 funds tracked by Wall St. Rank hold OM as of Q4 2022.

  • Alpha Paradigm Partners held 966 shares of Outset Medical worth $374K as of Q4 2022.
  • Outset Medical was a new Alpha Paradigm Partners position in Q4 2022.
  • Outset Medical made up 0.15% of Alpha Paradigm Partners's portfolio in Q4 2022, its #209 holding.
  • 152 funds tracked by Wall St. Rank held Outset Medical as of Q4 2022.

Based on Alpha Paradigm Partners's 13F filing for Q4 2022, filed 13 Feb 2023.